SAMe - 60 Tablets

A safe alternative to pharmaceuticals used for depression A first of its kind study from Harvard Medical School and Massachusetts General Hospital shows that the supplement that S-Adenosyl Methionine (SAMe), can be an effective support for patients with major depressive disorders who do not respond to their antidepressant medication. According to the investigators, led by George I. Papakostas, MD, of the Center for Treatment-Resistant Depression at Massachusetts General Hospital and Harvard Medical School in Boston, SAM-e treats depression. During the study, significantly more SAMe-treated than placebo-treated patients experienced a clinical response on the 17-item Hamilton Depression Rating Scale (HAM-D), which was the primary study outcome. Remission rates were also higher with SAMe than with placebo. “With each study, we continue to gain a better understanding of SAM-e’s role in treating depression. This new finding, albeit preliminary and in urgent need of replication, suggests s